Results 11 to 20 of about 4,182 (143)

The BNT162b2 vaccine effectiveness against new COVID-19 cases and complications of breakthrough cases: A nation-wide retrospective longitudinal multiple cohort analysis using individualised data

EBioMedicine, 2021
Background: The rapid vaccination campaign against COVID-19 in Israel relied on the BNT162b2 vaccine. We performed a longitudinal analysis of multiple cohorts, using individual data, to evaluate the effectiveness of the vaccine against new and ...
Aharona Glatman-Freedman, Michal Bromberg, Rita Dichtiar   +2 more
exaly   +3 more sources

Peptide-Based Vaccine against SARS-CoV-2: Peptide Antigen Discovery and Screening of Adjuvant Systems

Pharmaceutics, 2022
The SARS-CoV-2 virus has caused a global crisis, resulting in 0.5 billion infections and over 6 million deaths as of March 2022. Fortunately, infection and hospitalization rates were curbed due to the rollout of DNA and mRNA vaccines.
Ahmed O. Shalash, Armira Azuar, Harrison Y. R. Madge, Naphak Modhiran, Alberto A. Amarilla, Benjamin Liang, Alexander A. Khromykh, Waleed M. Hussein, Keith J. Chappell, Daniel Watterson, Paul R. Young, Mariusz Skwarczynski, Istvan Toth   +12 more
doaj   +2 more sources

Safety and reactogenicity of the BNT162b2 COVID-19 vaccine: Development, post-marketing surveillance, and real-world data

Human Vaccines & Immunotherapeutics
The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) led to urgent actions by innovators, vaccine developers, regulators, and other stakeholders to ensure public access to protective vaccines while maintaining regulatory ...
Frank van den Ouweland, Nicola Charpentier, Özlem Türeci, Ruben Rizzi, Federico J. Mensa, Claudia Lindemann, Shanti Pather   +6 more
doaj   +2 more sources

How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities

Trials
Objectives To establish if Black adults and adult ethnic minorities, defined as any group except White British, were represented in UK-based COVID-19 vaccination randomised controlled trials (RCTs) when compared to corresponding UK population proportions,
Hibba Herieka, Daphne Babalis, Evangelia Tzala, Shyam Budhathoki, Nicholas A. Johnson   +4 more
doaj   +2 more sources

Local reactions to the second dose of the BNT162 COVID ‐19 vaccine [PDF]

Dermatologic Therapy, 2021
Multiple strategies have been implemented worldwide to fight the burden of the pandemic caused by COVID-19, with vaccination being one of the most promising.1 Notably, the first vaccine to be authorized in Italy was the BNT162 mRNA-based vaccine, which has also been approved in the USA, United Kingdom, and Canada.1,2 As a matter of fact, RNA vaccines ...
Tammaro A., Adebanjo G. A. R., Parisella F. R., De Marco G., Rello J.   +4 more
openaire   +4 more sources

Newly diagnosed pediatric immunoglobulin A nephropathy after vaccination against SARS-CoV-2: a case report [PDF]

Childhood Kidney Diseases, 2022
The messenger RNA-based vaccine for the coronavirus disease 2019 (COVID-19) may induce glomerulonephritis, including immunoglobulin A nephropathy (IgAN).
Do Young Kim, Hyung Eun Yim, Min Hwa Son, Kee Hwan Yoo   +3 more
doaj   +1 more source

Side effects of the Pfizer BioNTech vaccine in health workers of a hospital in the southeast of Mexico

Journal of Infection in Developing Countries, 2022
Introduction: The goal of this study was to evaluate the side effects of application of the Pfizer BioNTech vaccine on the workers at a Mexican hospital. Methodology: A cross-sectional study was carried out, in which 1351 workers from a tertiary care
Jesús Arturo Ruiz-Quiñones, Víctor Manuel Narváez-Osorio, Oscar Antonio Ulín-Tejeda, Oscar Israel Flores-Barrientos, Samuel Suárez-Méndez, Guadalupe del Carmen Baeza-Flores   +5 more
doaj   +1 more source

Prevalence of indeterminate tuberculosis interferon‐gamma release assays in COVID‐19 patients: Systematic review and meta‐analysis

Health Science Reports, Volume 6, Issue 12, December 2023., 2023
Abstract Background and Aims The reliability of interferon‐gamma‐release‐assays (IGRAs) for tuberculosis (TB) testing in coronavirus disease 2019 (COVID‐19) patients is unknown. This study aimed to systematically review the prevalence of indeterminate TB‐IGRA following SARS‐CoV‐2 infection or vaccination and to review associated factors.
Aicha Ben Tekaya, Ameni Jerbi, Mouna Ben Sassi, Salma Mokaddem, Ines Mahmoud, Chedli Dziri, Leila Abdelmoula   +6 more
wiley   +1 more source

Sudden Sensorineural Hearing Loss Following Immunization With BNT162b2 or mRNA‐1273: A Danish Population‐Based Cohort Study

Otolaryngology–Head and Neck Surgery, Volume 169, Issue 6, Page 1472-1480, December 2023., 2023
Abstract Objective To compare the occurrence of sudden sensorineural hearing loss following immunization with BNT162b2 (Comirnaty®; Pfizer BioNTech) or mRNA‐1273 (Spikevax®; Moderna) to the occurrence among unvaccinated individuals. Study Design Cohort study.
Per Damkier, Brian Cleary, Jesper Hallas, Jesper H. Schmidt, Louise Ladebo, Peter B. Jensen, Lars Christian Lund   +6 more
wiley   +1 more source

Assessing the acceptability of COVID‐19 vaccine and its booster dose

Immunity, Inflammation and Disease, Volume 11, Issue 9, September 2023., 2023
Abstract Background and Objective Coronavirus disease of 2019 (COVID‐19) vaccinations are essential to control the pandemic and prevent severe COVID‐19 infections. This study aims to assess the acceptability of the COVID‐19 vaccine and the factors that impact the intention to take the COVID‐19 vaccine and its booster dose.
Sawsan Mubarak, Ashraf A'aqoulah, Hadeel AlGhawrie, Samir Albalas, Nisreen Innab   +4 more
wiley   +1 more source